45
CollPlant Biotechnologies closes $9.25M raise in Israel-based biotech
Company raise · Closed · Offering $9.2M · Sold $9.2M · Rehovot, Ireland · filed 2026-10-22
Placement agent engaged
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.
| Roger Dreiher Pomerantz | Director |
| Hugh Dreiher Evans | Director |
| Yehiel Tal | Chief Executive Officer and Director |
| Hadas Dreiher Horowitz | Vice President, Human Resources |
| Abraham Dreiher Havron | Director |
| Elana Gazal | Vice President, Research and Development |
| Alisa Dreiher Lask | Director |
| Philippe Bensimon | Vice President, Regulatory Affairs and Quality Assurance |
| Eran Rotem | Deputy Chief Executive Officer and Chief Financial Officer |
| Joseph Dreiher Zarzewsky | Director |
| Oren Fahimipoor | Vice President, Operations |
| Elan Dreiher Penn | Director |
Signed by Eran Rotem, Deputy Chief Executive Officer and Chief Financial Officer.
Placement agents / sales compensation: H.C. Wainwright & Co. LLC
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.